share_log
Moomoo 24/7 ·  Jan 8 07:30
Marker Therapeutics Says 'MultiTAA-specific T Cell Therapies Demonstrate Clinical Safety and Positive Clinical Data Across Multiple Indications'
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment